NHSA Revises 2024 NRDL Drug Information Based on Public Feedback
CompanyDrug

NHSA Revises 2024 NRDL Drug Information Based on Public Feedback

Eli Lilly China's Neuroscience VP Jiang Yifei Departs for New Opportunities
Company

Eli Lilly China’s Neuroscience VP Jiang Yifei Departs for New Opportunities

Fourier Intelligence Secures USD 109 Million in Series E Funding for Robotics Innovation
CompanyDeals

Fourier Intelligence Secures USD 109 Million in Series E Funding for Robotics Innovation

Astellas' Padcev and Keytruda Combo Cleared by NMPA for Urothelial Cancer
CompanyDrug

Astellas’ Padcev and Keytruda Combo Cleared by NMPA for Urothelial Cancer

HuidaGene Therapeutics Receives EMA Orphan Designation for HG004 Gene Therapy
CompanyDrug

HuidaGene Therapeutics Receives EMA Orphan Designation for HG004 Gene Therapy

China Medical System Licenses Alpha Cognition's Zunveyl for Dementia Treatment in Asia
CompanyDeals

China Medical System Licenses Alpha Cognition’s Zunveyl for Dementia Treatment in Asia

Huahai Pharmaceutical to Transfer Rights to Innovative Antidepressant HHT001 via Public Listing
CompanyDeals

Huahai Pharmaceutical to Transfer Rights to Innovative Antidepressant HHT001 via Public Listing

Mabwell's 9MW2821 Granted Breakthrough Therapy Designation by CDE for Urothelial Carcinoma
CompanyDrug

Mabwell’s 9MW2821 Granted Breakthrough Therapy Designation by CDE for Urothelial Carcinoma

Kelun Pharmaceutical's Generic Mulpleta Gains NMPA Approval in China
CompanyDrug

Kelun Pharmaceutical’s Generic Mulpleta Gains NMPA Approval in China

Alloy Therapeutics and Sanofi Collaborate on CNS Drug Development with AntiClastic Antisense Platform
CompanyDeals

Alloy Therapeutics and Sanofi Collaborate on CNS Drug Development with AntiClastic Antisense Platform

Fujian Cosunter's COVID-19 Therapy GST-HG171/ritonavir Approved in Macau
CompanyDrug

Fujian Cosunter’s COVID-19 Therapy GST-HG171/ritonavir Approved in Macau

Medtronic's Harmony TPV System Gains CE Mark for Minimally Invasive Heart Valve Treatment
CompanyMedical Device

Medtronic’s Harmony TPV System Gains CE Mark for Minimally Invasive Heart Valve Treatment